We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 172

Beyond gender biaslessons from the female libido drug’s path to approval
  • Nelson Mullins Riley & Scarborough LLP
  • USA
  • March 21 2014

Female libido drug candidate flibanserin has rekindled a debate about gender bias in the Food and Drug Administration's drug approval process. The